Testosterone Treatment In Hypogonadal Men: Prostate-Specific Antigen Level And Risk Of Prostate Cancer

Ebling, 1997, Development of prostate cancer after pituitary dysfunction: a report of 8 patients, Urology., 49, 564, 10.1016/S0090-4295(96)00541-9

Demark-Wahnefried, 1997, Serum androgens: associations with prostate cancer risk and hair patterning, J Androl., 18, 495, 10.1002/j.1939-4640.1997.tb01964.x

Morgentaler, 1996, Occult prostate cancer in men with low testosterone levels, JAMA., 276, 1904, 10.1001/jama.1996.03540230054035

Jackson, 1989, Prostatic complications of testosterone replacement therapy, Arch Intern Med., 149, 2365, 10.1001/archinte.1989.00390100157033

Svetec, 1997, The effect of parenteral testosterone replacement on prostate specific antigen in hypogonadal men with erectile dysfunction, J Urol., 158, 1775, 10.1016/S0022-5347(01)64126-0

Tenover, 1992, Effects of testosterone supplementation in the aging male, J Clin Endocrinol Metab., 75, 1092

Stamey, 1987, Prostate-specific antigen as serum marker for adenocarcinoma of the prostate, N Engl J Med., 317, 909, 10.1056/NEJM198710083171501

Cooper, 1998, Effect of exogenous testosterone on prostate volume, serum and semen prostate specific antigen levels in healthy young men, J Urol., 159, 441, 10.1016/S0022-5347(01)63944-2

Holmäng, 1993, Effect of long-term oral testosterone undecanoate treatment on prostate volume and serum prostate-specific antigen concentration in eugonadal middle-aged men, Prostate., 23, 99, 10.1002/pros.2990230203

Tripathy, 1997, Hormones and cancer, 724

Welsch, 1985, Host factors affecting the growth of carcinogen-induced rat mammary carcinomas: a review and tribute to Charles Brenton Huggins, Cancer Res., 45, 3415

Stamey, 1992, Adenocarcinoma of the prostate, 1159

Noble, 1977, The development of prostatic adenocarcinoma in Nb rats following prolonged sex hormone administration, Cancer Res., 37, 1929

Glantz, 1964, Cirrhosis and carcinoma of the prostate gland, J Urol., 91, 291, 10.1016/S0022-5347(17)64110-7

Zagars, 1997, Serum testosterone—a significant determinant of metastatic relapse for irradiated localized prostate cancer, Urology., 49, 327, 10.1016/S0090-4295(96)00619-X

Santner, 1998, Comparative rates of androgen production and metabolism in Caucasian and Chinese subjects, J Clin Endocrinol Metab., 83, 2104

Behre, 1994, Prostate volume in testosterone-treated and untreated hypogonadal men in comparison to age-matched normal controls, Clin Endocrinol (Oxf)., 40, 341, 10.1111/j.1365-2265.1994.tb03929.x

Gray, 1991, Age, disease, and changing sex hormone levels in middle-aged men: results of the Massachusetts Male Aging Study, J Clin Endocrinol Metab., 73, 1016, 10.1210/jcem-73-5-1016

Guay, 1991, Possible hypothalamic impotence: male counterpart to hypothalamic amenorrhea?, Urology., 38, 317, 10.1016/0090-4295(91)80143-U

Guay, 1995, Effect of raising endogenous testosterone levels in impotent men with secondary hypogonadism: double blind placebo-controlled trial with clomiphene citrate, J Clin Endocrinol Metab., 80, 3546

Yu, 1997, Testosterone pharmacokinetics after application of an investigational transdermal system in hypogonadal men, J Clin Pharmacol., 37, 1139, 10.1002/j.1552-4604.1997.tb04298.x

Hajjar, 1997, Outcomes of long-term testosterone replacement in older hypogonadal males: a retrospective analysis, J Clin Endocrinol Metab., 82, 3793, 10.1210/jcem.82.11.4387

Sih, 1997, Testosterone replacement in older hypogonadal men: a 12-month randomized controlled trial, J Clin Endocrinol Metab., 82, 1661, 10.1210/jcem.82.6.3988

Nankin, 1987, Hormone kinetics after intramuscular testosterone cypionate, Fertil Steril., 47, 1004, 10.1016/S0015-0282(16)59237-1

Snyder, 1999, Effect of testosterone treatment on bone mineral density in men over 65 years of age, J Clin Endocrinol Metab., 84, 1966

Curran, 1999, Dramatic rise in prostate-specific antigen after androgen replacement in a hypogonadal man with occult adenocarcinoma of the prostate, Urology., 53, 423, 10.1016/S0090-4295(98)00348-3